We are live on ! Find out more
FQ

First Quadrant Portfolio holdings

AUM $18M
1-Year Est. Return 24.2%
This Fund
S&P 500
This Quarter Est. Return
+11.3%
1 Year Est. Return
+24.2%
3 Year Est. Return
+90.61%
5 Year Est. Return
+144.39%
10 Year Est. Return
AUM
$930M
AUM Growth
+$72.8M
Cap. Flow
-$11.9M
Cap. Flow %
-1.28%
Top 10 Hldgs %
40.8%
Holding
562
New
47
Increased
68
Reduced
78
Closed
61

Top Buys

Rank Stock Value
1
INVA icon
Innoviva
INVA
+$2.05M
2
DNOW icon
DNOW Inc
DNOW
+$1.47M
3
GE icon
GE Aerospace
GE
+$1.36M
4
JPM icon
JPMorgan Chase
JPM
+$756K
5
CF icon
CF Industries
CF
+$650K

Sector Composition

Rank Sector Weight
1 Miscellaneous 23.22%
2 Technology 21.6%
3 Consumer Discretionary 12%
4 Healthcare 10.98%
5 Financials 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RYM
501
RYTHM Inc
RYM
$46.7M
-1
Closed -$32K
ANIK icon
502
Anika Therapeutics
ANIK
$280M
-343
Closed -$15K
OPTU
503
Optimum Communications Inc
OPTU
$377M
-16,594
Closed -$344K
BN icon
504
Brookfield
BN
$82.9B
-32,620
Closed -$941K
BRBR icon
505
BellRing Brands
BRBR
$1.06B
-1,254
Closed -$39K
BTU icon
506
Peabody Energy
BTU
$3.25B
-2,960
Closed -$44K
BXC icon
507
BlueLinx
BXC
$604M
-701
Closed -$34K
CAL icon
508
Caleres
CAL
$425M
-1,592
Closed -$35K
CGNT icon
509
Cognyte Software
CGNT
$626M
-200
Closed -$4K
CHWY icon
510
Chewy
CHWY
$8.52B
-523
Closed -$36K
CMS icon
511
CMS Energy
CMS
$20.7B
-555
Closed -$33K
COHR icon
512
Coherent
COHR
$53.1B
-1,060
Closed -$63K
CRM icon
513
Salesforce
CRM
$210B
-42
Closed -$11K
CSTL icon
514
Castle Biosciences
CSTL
$1.08B
-2,501
Closed -$166K
CTMX icon
515
CytomX Therapeutics
CTMX
$586M
-3,100
Closed -$16K
CXT icon
516
Crane NXT
CXT
$2.74B
-1,028
Closed -$34K
DOCU
517
DocuSign
DOCU
$13.4B
-132
Closed -$34K
EOLS icon
518
Evolus
EOLS
$522M
-5,346
Closed -$41K
EVC icon
519
Entravision Communication
EVC
$749M
-5,613
Closed -$40K
FF icon
520
Future Fuel
FF
$245M
-2,200
Closed -$16K
FL
521
DELISTED
Foot Locker
FL
-455
Closed -$21K
GDOT icon
522
Green Dot
GDOT
$752M
-2,700
Closed -$136K
HBIO icon
523
Harvard Bioscience
HBIO
$36.4M
-454
Closed -$32K
INGN icon
524
Inogen
INGN
$138M
-895
Closed -$39K
INO icon
525
Inovio Pharmaceuticals
INO
$120M
-2,950
Closed -$253K

Similar funds

First Quadrant's Q4 2021 Portfolio in Review

As of Q4 2021, First Quadrant held 562 positions worth $930M, up 8.5% from $857M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

First Quadrant's Q4 2021 filing shows 47 new, 68 increased, 78 reduced and 61 closed positions. Its largest new stake was Innoviva: 120,124 shares worth $2.07M. The largest sale was State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF, an estimated $4.11M.

By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

  • First Quadrant's largest Q4 2021 buy was Innoviva: 120,124 shares worth $2.07M.
  • First Quadrant added most to GE Aerospace in Q4 2021, an estimated $1.36M increase.
  • First Quadrant's biggest Q4 2021 reduction was State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF, cutting an estimated $4.11M.
  • First Quadrant fully exited HILL-ROM HOLDINGS, INC. in Q4 2021, selling an estimated $1.84M.
  • First Quadrant's ten largest holdings make up 41% of its $930M portfolio in Q4 2021.
  • First Quadrant opened 47 new positions and closed 61 in Q4 2021.
  • First Quadrant's portfolio value rose 8.5% quarter-over-quarter to $930M.

Based on First Quadrant's 13F filing for Q4 2021, filed 27 Jan 2022.